- Home
- ELTK vs OMGA Comparison
ELTK vs OMGA Comparison
Compare ELTK & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- OMGA
- Stock Information
- Founded
- ELTK 1970
- OMGA 2017
- Country
- ELTK Israel
- OMGA United States
- Employees
- ELTK N/A
- OMGA N/A
- Industry
- ELTK Electrical Products
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- ELTK Technology
- OMGA Health Care
- Exchange
- ELTK Nasdaq
- OMGA Nasdaq
- Market Cap
- ELTK 73.9M
- OMGA 74.5M
- IPO Year
- ELTK 1997
- OMGA 2021
- Fundamental
- Price
- ELTK $11.17
- OMGA $0.79
- Analyst Decision
- ELTK
- OMGA Strong Buy
- Analyst Count
- ELTK 0
- OMGA 5
- Target Price
- ELTK N/A
- OMGA $9.20
- AVG Volume (30 Days)
- ELTK 21.9K
- OMGA 338.6K
- Earning Date
- ELTK 11-19-2024
- OMGA 11-14-2024
- Dividend Yield
- ELTK 1.99%
- OMGA N/A
- EPS Growth
- ELTK N/A
- OMGA N/A
- EPS
- ELTK 0.85
- OMGA N/A
- Revenue
- ELTK $48,090,000.00
- OMGA $8,095,000.00
- Revenue This Year
- ELTK $5.41
- OMGA $127.25
- Revenue Next Year
- ELTK $12.11
- OMGA N/A
- P/E Ratio
- ELTK $13.00
- OMGA N/A
- Revenue Growth
- ELTK 7.22
- OMGA 185.04
- 52 Week Low
- ELTK $9.00
- OMGA $0.75
- 52 Week High
- ELTK $22.80
- OMGA $6.30
- Technical
- Relative Strength Index (RSI)
- ELTK 54.37
- OMGA 32.92
- Support Level
- ELTK $10.82
- OMGA $1.06
- Resistance Level
- ELTK $12.00
- OMGA $0.82
- Average True Range (ATR)
- ELTK 0.41
- OMGA 0.10
- MACD
- ELTK 0.03
- OMGA -0.03
- Stochastic Oscillator
- ELTK 42.36
- OMGA 7.83
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.